This study was aimed to develop chitosan-calcium alginate-tween 80 nanoparticles as drug carrier to reduce the dosing frequency of isoniazid, an anti tuberculosis drug. In this work calcium alginate was blended with different composition of isoniazid-chitosan-tween 80. The nanoparticles were characterized to determine the particles size, functional groups, surface morphology,
Introduction
Isoniazid is first line drug for use in therapy of tuberculosis and it is included in the list of recommended drug for treatment of M. tuberculosis. Isoniazid has short biological half life so that it must to be consumed daily once in the treatment of tuberculosis for a six months period [1] . The development of controlled release delivery of isoniazid using nanoparticles clearly be advantageous. This system can to improve therapeutic efficacy and to reduce adverse effects.. Polymeric nanoparticles have unique characteristics for delivery antimicrobial drug; using polymers have stable structure with controlled size distribution [2, 3] . The nanoparticles sizes and drug release profiles can be design by selecting different polymer lengths, surfactants, and organic solvents during the synthesis. The surface of nanoparticle typically contain functional groups that can be chemically modified with either drug or targeting ligands [4, 5] . This material can be used to penetrating blood among capillaries and enter the cells in body [6] . Some biodegradable polymer used for these drug delivery purpose are chitosanpolycaprolactone [7] chitosan-sodium alginate-cloisite [8] , glycol-chitosan [9] , and cyclodextrin-chitosan [10] .Chitosan is a biopolymer has unique characteristic biodegradable, biocompatible, bioactivity and non toxic [6, 10] . Alginate soluble polysaccharide compose guluronic and mannuronic acid. Alginate has properties mucoadhesive, biodegradable, and biocompatible [6] . In this research, chitosan was combinated with alginate and surfactant tween 80 (polietylene sorbitanmonooleat) for matrix encapsulation. Tween 80 is nonionic surfactant with high HLB and low cmc so that it can be a useful approach to improve bioavailability, decrease surface tension and suitable for drug delivery [11] [12] [13] [14] [15] .
Materials and Methods
Sodium alginate, CaCl2, glutaraldehyde, Acetic acid, NaOH, chloride buffer solution pH 1.2, phosphate buffer solution pH 7.4 were purchase from PT Dianum Indonesia; isoniazid and Tween 80 (polyethylene sorbitanmonooleat) was obtained from PT Kalbe Farma Indonesia. Chitosan with 85% deacetylated was obtained from ChemIndo Indonesia and other chemicals were used as analytical grade and purchase from Merck Company.
Encapsulation isoniazid on chitosan calcium alginate tween 80. The required quantity of sodium alginate 250 mg was dissolved in 500 mL distilled water. The active drug, isoniazid (0.5g) was dissolved in 50 mL distilled water and was added in sodium alginate solution. About 5 ml of tween 80 with variation concentration was added to the mixture and was dropped into 100 mL of 0.1 M calcium chloride and washed with demineralization water until the nanoparticles were free from chloride ion. The nanoparticles were soaked in chitosan solution 0.1% (w/v) for 10 minutes. After that the nanoparticles were dried at room temperature until dry.
Efficiency of encapsulation. An amount of 50 mg nanoparticles of each variant were digested and incubated in 100 mL of 0.1 M NaOH for 10 minutes. The suspension was centrifuged at 5000 rpm for 30 min. The supernatant was assayed by UV-vis Spectrophotometer at the wavelength 236 nm.
In vitro measurement of drug release. The in vitro measurement of drug release of encapsulated isoniazid were performed at two simulation medium: 1.2 pH which is simulated gastric and 7.4 pH which is simulated intestinal medium. As much as 500 mg nanoparticles were placed at the dissolution chamber on gastric medium and the dissolution test was done for two hours. Samples were transferred into simulated intestinal solution pH 7.4 and dissolution test was performed up to 60 hours. A aliquots of 25 ml were sampled from gastric and intestinal medium each time for analyzing the isoniazid content. The amount of isoniazid released was analyzed using UV Spectrophotometer at 236 nm.
Results and Discussion
The results of morfology analysis in Fig. 1 showed that nanoparticles isoniazid encapsulated were prepared in this research were found to be spherical and without aggregation. Tween 80 function as surfactant has effect in surface morphology of nanoparticles are smooth and the spheres are uniform.
Fig.1 SEM image of encapsulated isoniazid
In the process of nanoparticles synthesis was added tween 80. This surfactant was adsorpt by surface of nanoparticle to prevent of aggregation so that the nanoparticles surface of more porous, an uniform in pore size. Because of its pores was not closed by aggregation so that the drug performance will be effective for controlled release system..
Analysis of particles size showed that tween 80 has effect in particles size. Chitosan ca alginate-isoniazid-tween 80 has majority particle size diameter from 50 to 750 nm. Table 1 showed that particles size depends upon the tween 80 concentration. Tween 80 is nonionic surfactant with HLB (hydrophile lipophile balance) high. At this research, the dispersion medium of matrix of chitosan alginate system was W/O (water in oil) so that usage of tween 80 as surfactant better in working. Usage Tween 80 can reduce surface tension so that can degrade particle diameter. Ionic interaction between the matrix and isoniazid increase entrapment of the isoniazid in matrix. The encapsulation efficiency of isoniazid in matrix was influenced by amount of nanoparticle, if amount of nanoperticle increase the surface area of particle increase too, so that efficiecy encapsulation is bigger. Research data indicate that usage of Tween 80 produced of nanoparticles were more than (formula D) compared to without use tween 80 (formula A)..
, Fig 2.Efficiency encapsulation isoniazid in variation concentration tween 80
The pattern release of drug can be demontrated to through test of dissolution in gastric and interstinal simulated medium. The pattern drugs release data presented in Figure 3 indicate that if pH condition medium incerase from 1.2 (gastric medium) to 7.4 (interstinal medium), the cumulative release is observed increase for all composites. From Fig. 3 , it is seen that formula D shown longer drug release rate than the other composition. Thus, drug release depends upon the natural of the polymer as well as pH of simulation medium. This suggests that the drug in the blend can be used to be suitable for basic environment of the lange intestine, colon, and rectal mucosa for which there are different emptying times. In medium pH 7.4 more than 90% isoniazid is released from matrix within 60 hours, but in medium pH 1.2 about 30% isoniazid is released. Futher the electrostatic interaction of matrix is more easily broken at pH 7.4 than at pH 1.2, so that isoniazid being released more rapidly at pH 7.4 
Conclusions
The results study showed that combination chitosan calcium alginate and Tween 80 on encapsulation of isoniazid is greats potential for anti tuberculosis drug carrier as an alternative to the conventional dosage. The some effects of tween 80 on nanoparticles formed were the nanoparticles have characteristics surface smooth, uniform and its pores do not closing by aggregation so that drug performance will be effective. Dissolustion release isoniazid in pH 1.2 and pH 7.4 indicate more than 90% isoniazid is release from matrix and in pH 1.2 about 30%.
